FCA authorised · FRN 724952 0117 325 0027Quote & buy →
Apex Insurance Brokers
Speak to a brokerGet a quote →

Aipedia: Aesthetics clinics

AI questionnaires and remote Botox prescribing

An AI questionnaire cannot replace the physical examination that GMC guidance requires before a doctor prescribes botulinum toxin for cosmetic use. Prescribers who sign off toxin for non-medical injectors on the strength of an online form carry the regulatory and claims risk.

In short

Some prescribing services may use online or AI-driven forms to collect medical histories and approve botulinum toxin for patients treated by non-medical injectors. GMC cosmetic guidance para 11 says doctors must physically examine patients before prescribing injectable cosmetic medicines and must not prescribe them online, by telephone or video, or at the request of others for patients they have not examined. The prescriber remains accountable for the prescription, whoever injects. A form that decides eligibility without meaningful human involvement also engages the automated decision safeguards in data protection law. Prescriber cover may not respond to prescribing outside professional guidance.

How online forms are being used

Non-medical injectors cannot prescribe botulinum toxin, so they rely on a prescriber. Some arrangements may run through a web form or app: the client answers questions about health, medicines and allergies, uploads a photo, and an algorithm flags anyone unsuitable. A prescriber then approves the batch, sometimes without speaking to the client. Newer tools may use generative AI to summarise answers or suggest a dose. The model is attractive for speed and cost, but it shifts the clinical judgement from the prescriber to the form.

The duties that apply

What can go wrong

Illustrative scenario: a prescriber approves toxin through an app for clients of several non-medical injectors. The form screens for listed conditions, but one client has a neuromuscular condition they did not recognise as relevant. After treatment the client develops significant weakness and brings a claim against the injector and the prescriber. The prescriber's regulator also investigates how they assessed the patient.

Other risks include doses suggested by software that the prescriber did not check, prescriptions issued in volume for stock rather than named patients, and records that show only an automated approval.

The injector is exposed too. If the form approved a client the injector had doubts about, the injector cannot point to the prescription as a defence to their own failure to assess, warn or seek consent. Where the prescriber is hard to reach after treatment, delays in managing a complication add a second allegation. In a claim, the records of who saw the patient, when and what they checked will be examined closely, and an audit trail showing only a software approval and a signature is difficult to defend.

How PI usually responds

Indemnity is compulsory for doctors, nurses, dentists and pharmacists, and NHS indemnity does not cover private practice. A prescriber's cover usually responds to claims arising from their prescribing, subject to the policy terms, but insurers and defence organisations may decline or limit help where prescribing breached professional guidance. One medical defence organisation has said it helps with AI use only where a human remains the decision maker. A non-medical injector needs their own treatment-risk cover; the prescriber's policy does not protect them. See prescriber cover for toxins and fillers and doctors and indemnity requirements.

Practical controls

Related: AI in weight-loss injection services, training for non-medical injectors, AI triage and online consultation for doctors and the aesthetics AI hub.

How Apex helps

Apex arranges indemnity for prescribers and the injectors they work with. A broker reviews whether your policy fits your prescribing model and how it treats AI-assisted assessment.

Sources

Frequently asked

Can I prescribe Botox after an online AI consultation?

Not as a doctor following GMC guidance. Para 11 requires a physical examination before prescribing injectable cosmetic medicines and rules out prescribing online, by video or telephone, or at the request of others for patients you have not examined.

Who is liable if a client is harmed: the injector or the prescriber?

Potentially both. The prescriber is accountable for the decision to prescribe and the injector for the treatment and consent. Each needs their own cover; neither policy usually protects the other.

Can AI help with prescribing at all?

It can gather a history before a face-to-face appointment, flag interactions or summarise records for the prescriber to check. The decision, examination and consent must stay with qualified people.

Check your indemnity covers how you use AI

Tell us about your practice and the work you do. A broker will review how your current cover treats AI-assisted work, or arrange new cover. No fee for a quote. Or call 0117 325 0027.

Start an indemnity quote Request a callback

Apex Insurance Brokers Limited is authorised and regulated by the Financial Conduct Authority. Registered in England and Wales, company number 07014570. This page is general information about how AI is used in the profession and how insurance may respond. It is not legal, regulatory or insurance advice on your circumstances, and it does not guarantee that cover will be available or on what terms.